Rheumatoid Arthritis: A Brief Overview of the Treatment
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follo...
Saved in:
| Published in | Medical principles and practice Vol. 27; no. 6; pp. 501 - 507 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Basel, Switzerland
S. Karger AG
01.01.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA. |
|---|---|
| AbstractList | Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA. Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA.Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA. |
| Author | Rizvi, Syed A.A. Do, Duc P. Bullock, Jacqueline Ahmed, Jasmin Saleh, Ayman M. Ahmed, Sultan S. Ansari, Rais A. |
| AuthorAffiliation | 1 Keiser University, Fort Lauderdale, Florida, USA 2 School of Pharmacy, Hampton University, Hampton, Virginia, USA 6 Larkin Community Hospital, Miami, Florida, USA 3 King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center (KAIMRC), Jeddah, Saudi Arabia 5 University of Georgia, Athens, Georgia, USA 4 Nova Southeastern University, Fort Lauderdale, Florida, USA |
| AuthorAffiliation_xml | – name: 4 Nova Southeastern University, Fort Lauderdale, Florida, USA – name: 1 Keiser University, Fort Lauderdale, Florida, USA – name: 6 Larkin Community Hospital, Miami, Florida, USA – name: 3 King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center (KAIMRC), Jeddah, Saudi Arabia – name: 5 University of Georgia, Athens, Georgia, USA – name: 2 School of Pharmacy, Hampton University, Hampton, Virginia, USA |
| Author_xml | – sequence: 1 givenname: Jacqueline surname: Bullock fullname: Bullock, Jacqueline – sequence: 2 givenname: Syed A.A. surname: Rizvi fullname: Rizvi, Syed A.A. email: salehay@ksau-hs.edu.sa, salehay@ngha.med.sa – sequence: 3 givenname: Ayman M. surname: Saleh fullname: Saleh, Ayman M. email: salehay@ksau-hs.edu.sa, salehay@ngha.med.sa – sequence: 4 givenname: Sultan S. surname: Ahmed fullname: Ahmed, Sultan S. email: salehay@ksau-hs.edu.sa, salehay@ngha.med.sa – sequence: 5 givenname: Duc P. surname: Do fullname: Do, Duc P. – sequence: 6 givenname: Rais A. surname: Ansari fullname: Ansari, Rais A. – sequence: 7 givenname: Jasmin surname: Ahmed fullname: Ahmed, Jasmin email: salehay@ksau-hs.edu.sa, salehay@ngha.med.sa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30173215$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkc1P3DAQxa2Kiq9y6L2qInFpDykef-CYQ6UtagsSFaiiZ8ubjFnTJN7aziL--xotrFrEaSy937x5ntkjW2MYkZC3QD8BSH1EKRWac01fkV0QjNcUJGyVNwWolVSwQ_ZSui1YwzndJjucguIM5C5RPxc4DTYH31WzmBfRZ59Oqln1JXp01eUK48rjXRVclRdYXUe0ecAxvyGvne0THjzWffLr29fr07P64vL7-ensom5lI3NtRQPaCepQaoVMa0TLJZ070FwpwFaDcnMGnRVUKqG40BRRS97NRUM7yffJ57XvcpoP2LVldLS9WUY_2HhvgvXmf2X0C3MTVuZYMMaZLgYfHg1i-DNhymbwqcW-tyOGKRlGtaa8OeasoIfP0NswxbF8z7CyMQ2cN02h3v-baBPlaacFOFoDbQwpRXSm9dlmHx4C-t4ANQ9XM5urlY6PzzqeTF9i363Z3zbeYNyQG_nwRfnH1dWaMMvO8b85aqjz |
| CitedBy_id | crossref_primary_10_1016_j_bbrep_2024_101867 crossref_primary_10_1016_j_drudis_2024_104071 crossref_primary_10_1016_j_ijbiomac_2024_130864 crossref_primary_10_1016_j_jconrel_2020_12_025 crossref_primary_10_3390_ijms25063386 crossref_primary_10_1007_s13205_024_03990_z crossref_primary_10_5435_JAAOSGlobal_D_22_00209 crossref_primary_10_3390_nano12081299 crossref_primary_10_1016_j_heliyon_2023_e23264 crossref_primary_10_1021_acs_biomac_3c01361 crossref_primary_10_1097_NR9_0000000000000027 crossref_primary_10_1007_s12195_020_00655_8 crossref_primary_10_3389_fimmu_2021_631291 crossref_primary_10_23736_S0393_3660_19_04183_4 crossref_primary_10_3934_mbe_2023902 crossref_primary_10_2174_0115733971266397231122080247 crossref_primary_10_3389_fonc_2020_00518 crossref_primary_10_1038_s41584_023_00992_8 crossref_primary_10_1371_journal_pone_0312072 crossref_primary_10_1038_s41540_023_00294_5 crossref_primary_10_3390_ph17111504 crossref_primary_10_1177_09733698241290298 crossref_primary_10_1080_15569527_2022_2127749 crossref_primary_10_1021_acsabm_3c00327 crossref_primary_10_22159_ijap_2023v15i6_49122 crossref_primary_10_1002_cbdv_202401606 crossref_primary_10_1007_s10544_021_00604_w crossref_primary_10_1016_j_ctcp_2021_101524 crossref_primary_10_1007_s12010_023_04451_8 crossref_primary_10_1186_s40780_023_00312_y crossref_primary_10_1016_j_jddst_2023_104241 crossref_primary_10_31083_j_fbl2904153 crossref_primary_10_1016_j_cyto_2022_156074 crossref_primary_10_3389_fcell_2022_957800 crossref_primary_10_52711_0974_360X_2023_00660 crossref_primary_10_1007_s11030_024_10958_x crossref_primary_10_1186_s13075_024_03426_2 crossref_primary_10_1007_s40744_024_00725_7 crossref_primary_10_2174_1573397118666220804162313 crossref_primary_10_4236_ojra_2021_113013 crossref_primary_10_1016_j_arr_2023_101927 crossref_primary_10_1016_j_biopha_2023_114620 crossref_primary_10_1021_acsptsci_4c00067 crossref_primary_10_3389_fmicb_2022_839015 crossref_primary_10_3389_fphar_2022_927179 crossref_primary_10_1002_ptr_8187 crossref_primary_10_7759_cureus_41883 crossref_primary_10_3390_app13042205 crossref_primary_10_1080_14737167_2024_2411431 crossref_primary_10_1016_j_micromeso_2022_112152 crossref_primary_10_2217_bmm_2021_0070 crossref_primary_10_3390_ijms24087623 crossref_primary_10_53365_nrfhh_196884 crossref_primary_10_26693_jmbs07_01_062 crossref_primary_10_12688_f1000research_125446_1 crossref_primary_10_3389_fphar_2024_1406939 crossref_primary_10_1016_j_transproceed_2024_12_020 crossref_primary_10_37285_ijpsn_2024_17_4_3 crossref_primary_10_1093_rheumatology_keae086 crossref_primary_10_5114_reum_189780 crossref_primary_10_1016_j_mehy_2022_110896 crossref_primary_10_1093_eurheartj_ehae108 crossref_primary_10_1016_j_matpr_2022_05_299 crossref_primary_10_3389_fimmu_2023_1223810 crossref_primary_10_3390_ijms23094832 crossref_primary_10_1007_s13346_023_01503_8 crossref_primary_10_1080_10717544_2023_2173332 crossref_primary_10_1080_07391102_2023_2203234 crossref_primary_10_1007_s00296_023_05382_7 crossref_primary_10_52420_2071_5943_2022_21_2_26_37 crossref_primary_10_1186_s12962_024_00522_7 crossref_primary_10_3390_jcm12237265 crossref_primary_10_7759_cureus_30553 crossref_primary_10_1016_j_apsb_2020_10_008 crossref_primary_10_1111_jocn_16236 crossref_primary_10_4103_injr_injr_69_21 crossref_primary_10_1007_s12668_024_01742_0 crossref_primary_10_4103_ijo_IJO_2024_22 crossref_primary_10_12677_ACM_2023_134978 crossref_primary_10_1038_s41598_023_37729_2 crossref_primary_10_7759_cureus_40580 crossref_primary_10_56082_annalsarscimed_2021_1_25 crossref_primary_10_2174_1568026622666220107105233 crossref_primary_10_1016_j_jddst_2025_106705 crossref_primary_10_1016_j_molliq_2022_119851 crossref_primary_10_1007_s11030_024_10910_z crossref_primary_10_18231_j_ijor_2023_002 crossref_primary_10_1039_D4EN00488D crossref_primary_10_1186_s43166_025_00306_8 crossref_primary_10_1016_j_bbrep_2022_101341 crossref_primary_10_1016_j_ijpharm_2025_125206 crossref_primary_10_1107_S2053229624010106 crossref_primary_10_21931_RB_2023_08_01_53 crossref_primary_10_1016_j_chemosphere_2022_136995 crossref_primary_10_2147_IJWH_S482294 crossref_primary_10_1016_j_jclinepi_2024_111481 crossref_primary_10_1007_s10856_021_06547_1 crossref_primary_10_1007_s10067_022_06052_y crossref_primary_10_1038_s41598_022_26106_0 crossref_primary_10_3389_fphar_2022_846830 crossref_primary_10_3390_ijerph182413216 crossref_primary_10_1016_j_biopha_2023_115184 crossref_primary_10_1016_j_molliq_2023_123105 crossref_primary_10_1080_07391102_2024_2330713 crossref_primary_10_1053_j_ro_2024_08_002 crossref_primary_10_1111_jphp_13238 crossref_primary_10_1093_bbb_zbab049 crossref_primary_10_70471_y4mv8218 crossref_primary_10_7326_aimcc_2022_1149 crossref_primary_10_4103_ara_ara_11_24 crossref_primary_10_1177_03946320221086084 crossref_primary_10_1002_smll_202407813 crossref_primary_10_1111_bph_17312 crossref_primary_10_1016_j_phrs_2022_106202 crossref_primary_10_1097_MD_0000000000036595 crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023048324 crossref_primary_10_1155_2022_1717614 crossref_primary_10_4103_jin_jin_141_23 crossref_primary_10_1186_s12967_024_05105_x crossref_primary_10_26685_urncst_289 crossref_primary_10_1007_s11418_024_01801_6 crossref_primary_10_3389_fimmu_2021_686155 crossref_primary_10_1111_cbdd_14268 crossref_primary_10_1016_j_ajps_2024_100887 crossref_primary_10_1016_j_jsbmb_2025_106680 crossref_primary_10_2139_ssrn_4008138 crossref_primary_10_3390_jcm10235694 crossref_primary_10_3923_ijp_2024_547_551 crossref_primary_10_1016_j_biopha_2019_108909 crossref_primary_10_1007_s12668_024_01787_1 crossref_primary_10_1007_s11916_021_00973_0 crossref_primary_10_1016_j_autrev_2020_102735 crossref_primary_10_1016_j_rcreue_2021_01_007 crossref_primary_10_1016_j_jep_2022_115202 crossref_primary_10_18231_j_ijos_2024_015 crossref_primary_10_1016_j_drudis_2023_103671 crossref_primary_10_1007_s12672_021_00439_0 crossref_primary_10_1007_s10067_021_05945_8 crossref_primary_10_1016_j_bcab_2024_103064 crossref_primary_10_1016_j_mito_2023_10_004 crossref_primary_10_2174_0118715230272263231103094710 crossref_primary_10_1016_j_jep_2024_119160 crossref_primary_10_1016_j_bioadv_2024_214008 crossref_primary_10_1016_j_cis_2020_102273 crossref_primary_10_1088_2043_6262_ad09c6 crossref_primary_10_1590_1414_431x2024e13913 crossref_primary_10_1080_10837450_2023_2289170 crossref_primary_10_1016_j_inoche_2024_113737 crossref_primary_10_1016_j_intimp_2022_108794 crossref_primary_10_7759_cureus_61580 crossref_primary_10_1038_s41598_023_42111_3 crossref_primary_10_2139_ssrn_4176841 crossref_primary_10_1016_j_jddst_2024_106493 crossref_primary_10_1007_s11101_024_09955_7 crossref_primary_10_1186_s43094_023_00540_x crossref_primary_10_4103_jras_jras_183_23 crossref_primary_10_12968_pnur_2022_33_7_276 crossref_primary_10_1007_s11010_022_04452_x crossref_primary_10_1007_s12013_024_01316_7 crossref_primary_10_1007_s40264_024_01490_w crossref_primary_10_1111_1756_185X_14874 crossref_primary_10_2174_0115733971288433240408062359 crossref_primary_10_1515_nipt_2024_0023 crossref_primary_10_29254_2077_4214_2023_3_170_386_394 crossref_primary_10_1007_s10067_024_06892_w crossref_primary_10_1016_j_cegh_2023_101373 crossref_primary_10_52711_2231_5691_2022_00051 crossref_primary_10_1016_j_molstruc_2024_138430 crossref_primary_10_1186_s13018_024_05221_w crossref_primary_10_7759_cureus_38214 crossref_primary_10_14233_ajomc_2022_AJOMC_P357 crossref_primary_10_1002_cbdv_202402566 crossref_primary_10_1007_s10787_022_00957_5 crossref_primary_10_1177_15589447211040877 crossref_primary_10_1088_1755_1315_852_1_012075 crossref_primary_10_1016_j_ijpharm_2024_124159 crossref_primary_10_2174_2772434418666230406083149 crossref_primary_10_54097_hset_v54i_9750 crossref_primary_10_1515_zpch_2023_0538 crossref_primary_10_1177_10738584241293049 crossref_primary_10_2174_012210299X276015231102052904 crossref_primary_10_3390_jpm13101479 crossref_primary_10_1016_j_phymed_2025_156401 crossref_primary_10_1186_s13063_024_08372_7 crossref_primary_10_1155_2020_4348709 crossref_primary_10_1016_j_ijpharm_2021_121137 crossref_primary_10_1055_a_2463_8297 crossref_primary_10_1016_j_intimp_2022_108644 crossref_primary_10_17925_RMD_2023_2_1_2 crossref_primary_10_1186_s13075_024_03456_w crossref_primary_10_1016_j_ejr_2023_12_001 crossref_primary_10_3390_pharmaceutics15030736 crossref_primary_10_1007_s40744_023_00533_5 crossref_primary_10_21518_ms2023_398 crossref_primary_10_18311_jnr_2024_36359 crossref_primary_10_1021_acsomega_3c00692 crossref_primary_10_3390_jcm13040973 crossref_primary_10_1002_jobm_202300141 crossref_primary_10_1186_s43166_022_00126_0 crossref_primary_10_1021_acsomega_1c01320 crossref_primary_10_3390_ijms23073628 crossref_primary_10_2174_1381612827666210525164734 crossref_primary_10_1016_j_ijpharm_2021_121242 crossref_primary_10_2174_1573401318666220601150053 crossref_primary_10_1007_s00590_024_03842_9 crossref_primary_10_1007_s10528_023_10383_z crossref_primary_10_3389_fimmu_2022_936995 crossref_primary_10_3390_biom13101501 crossref_primary_10_31083_j_jin2003081 crossref_primary_10_17816_DD508786 crossref_primary_10_3389_fmolb_2023_1065171 crossref_primary_10_1080_08820139_2024_2301997 crossref_primary_10_1007_s10787_021_00816_9 crossref_primary_10_1007_s10787_024_01463_6 crossref_primary_10_1080_2314808X_2022_2156683 crossref_primary_10_3390_healthcare12202017 crossref_primary_10_1177_0036933020969006 crossref_primary_10_1007_s10787_022_00979_z crossref_primary_10_3390_jcm13020403 crossref_primary_10_1021_acs_jafc_2c05802 crossref_primary_10_2174_1381612826666200523174108 crossref_primary_10_1007_s00296_022_05142_z crossref_primary_10_1002_msc_1612 crossref_primary_10_3390_ijms242015347 crossref_primary_10_3389_fmed_2024_1371461 crossref_primary_10_1155_2022_7795602 crossref_primary_10_3390_pharmaceutics13071004 crossref_primary_10_1038_s41540_024_00482_x crossref_primary_10_3389_fmed_2022_1078350 crossref_primary_10_1208_s12249_023_02648_y crossref_primary_10_25122_jml_2023_0158 crossref_primary_10_3390_ijms221910325 crossref_primary_10_2174_1566523221666210916113609 crossref_primary_10_1097_j_pain_0000000000001896 crossref_primary_10_3389_fimmu_2024_1492878 crossref_primary_10_1177_09733698241232849 crossref_primary_10_1016_j_jsps_2020_06_021 crossref_primary_10_3390_cimb44030069 crossref_primary_10_2147_OARRR_S412942 crossref_primary_10_1155_2023_6641018 crossref_primary_10_1016_j_nxnano_2025_100135 crossref_primary_10_1021_acs_biomac_2c00144 crossref_primary_10_3389_fphar_2024_1374485 crossref_primary_10_2174_0113852728289430231227042754 crossref_primary_10_1016_j_cegh_2022_100969 crossref_primary_10_3390_pharmacy10060138 crossref_primary_10_37349_ei_2024_00146 crossref_primary_10_1177_0976500X231211394 crossref_primary_10_1007_s10067_024_07285_9 crossref_primary_10_25040_lkv2022_01_02_021 crossref_primary_10_3390_medicina60071156 crossref_primary_10_1136_bmjopen_2021_050540 crossref_primary_10_1016_j_trac_2024_117763 crossref_primary_10_1002_joa3_12995 crossref_primary_10_1016_j_jor_2025_03_032 crossref_primary_10_3390_foods11223576 crossref_primary_10_1136_rmdopen_2021_001615 crossref_primary_10_1111_cts_70156 crossref_primary_10_1186_s13075_022_02957_w crossref_primary_10_3389_fimmu_2022_956181 crossref_primary_10_3390_gels10100634 crossref_primary_10_3390_ijms22083915 crossref_primary_10_1038_s41584_024_01118_4 crossref_primary_10_1186_s13075_024_03452_0 crossref_primary_10_1136_rmdopen_2024_004857 crossref_primary_10_1002_ptr_7417 crossref_primary_10_7759_cureus_38739 crossref_primary_10_21101_cejph_a7892 crossref_primary_10_3390_ijms22031185 crossref_primary_10_1016_j_jep_2023_117502 crossref_primary_10_3389_fnbeh_2022_850623 crossref_primary_10_1093_qjmed_hcab316 crossref_primary_10_7759_cureus_78474 crossref_primary_10_1111_1756_185X_14462 crossref_primary_10_1016_j_arabjc_2023_104881 crossref_primary_10_3390_nu15030676 crossref_primary_10_2174_1872210517666230822100324 crossref_primary_10_1016_j_jddst_2023_104742 crossref_primary_10_1186_s41936_024_00398_2 crossref_primary_10_2174_1573409919666230516110622 crossref_primary_10_36290_csf_2020_019 crossref_primary_10_1016_j_jddst_2023_104985 crossref_primary_10_1111_cbdd_14582 crossref_primary_10_3390_jcm13175297 crossref_primary_10_1080_10717544_2025_2459772 crossref_primary_10_3390_rheumato5010003 crossref_primary_10_1016_j_jphotochem_2023_114713 crossref_primary_10_3390_brainsci13111532 crossref_primary_10_1007_s00296_022_05251_9 crossref_primary_10_3389_fimmu_2022_1001598 crossref_primary_10_3390_nu13103506 crossref_primary_10_52711_0974_360X_2021_00892 crossref_primary_10_7759_cureus_48852 crossref_primary_10_3390_pharmaceutics13050736 crossref_primary_10_2144_fsoa_2023_0248 crossref_primary_10_1016_j_intimp_2023_109740 crossref_primary_10_1021_acsomega_3c09788 crossref_primary_10_1186_s13018_021_02550_y crossref_primary_10_3390_diagnostics14171911 crossref_primary_10_1016_j_micpath_2024_107239 crossref_primary_10_3390_nu16193378 crossref_primary_10_1097_MNM_0000000000001822 crossref_primary_10_1016_j_ijpharm_2023_122776 crossref_primary_10_1097_gscm_0000000000000039 crossref_primary_10_1186_s12891_024_07496_w crossref_primary_10_1016_j_biopha_2021_111880 crossref_primary_10_52711_0974_360X_2024_00603 crossref_primary_10_1002_adtp_202100159 crossref_primary_10_3390_molecules28207126 crossref_primary_10_3390_life14091136 crossref_primary_10_3389_fimmu_2024_1352251 crossref_primary_10_1007_s10787_025_01669_2 crossref_primary_10_1016_j_bj_2023_100655 crossref_primary_10_7759_cureus_14631 crossref_primary_10_61411_rsc202450117 crossref_primary_10_2144_fsoa_2023_0134 crossref_primary_10_1002_bmc_5923 crossref_primary_10_3390_jpm13111550 crossref_primary_10_4236_scd_2024_141001 crossref_primary_10_1002_jcb_30690 crossref_primary_10_1039_D1FO01078F crossref_primary_10_1080_02652048_2023_2194414 crossref_primary_10_1002_jssc_201900678 crossref_primary_10_3390_molecules28114414 crossref_primary_10_1016_j_talanta_2023_125532 crossref_primary_10_1080_15360288_2021_1973647 crossref_primary_10_1097_MS9_0000000000002890 crossref_primary_10_3390_molecules28124699 crossref_primary_10_3390_nu15051106 crossref_primary_10_3389_fimmu_2022_867260 crossref_primary_10_2174_1573397115666191127141801 crossref_primary_10_1016_j_bioorg_2024_107689 crossref_primary_10_1007_s10753_023_01927_x crossref_primary_10_1007_s11033_025_10366_w crossref_primary_10_1016_j_jddst_2024_105928 crossref_primary_10_1093_mr_roae002 crossref_primary_10_3389_fcell_2021_658984 crossref_primary_10_2196_39881 crossref_primary_10_1186_s41927_024_00418_2 crossref_primary_10_2139_ssrn_3947645 crossref_primary_10_1007_s10753_023_01795_5 crossref_primary_10_1002_slct_202402035 crossref_primary_10_1136_ard_2024_226385 crossref_primary_10_3390_cells11213410 crossref_primary_10_3389_fphar_2024_1488790 crossref_primary_10_1155_2024_8838626 crossref_primary_10_1166_jbn_2023_3621 crossref_primary_10_3389_fimmu_2024_1510693 crossref_primary_10_1016_j_jddst_2021_102920 crossref_primary_10_1186_s13256_021_03141_5 crossref_primary_10_1021_acs_molpharmaceut_3c00581 crossref_primary_10_3389_fcell_2023_1166308 crossref_primary_10_2174_0929867331666230815112818 crossref_primary_10_3390_antiox14020171 crossref_primary_10_3390_molecules28062430 crossref_primary_10_4103_mgmj_mgmj_153_23 crossref_primary_10_3390_ph17030391 crossref_primary_10_4103_bbrj_bbrj_37_25 crossref_primary_10_1016_j_carbpol_2022_119674 crossref_primary_10_3390_cells13070618 crossref_primary_10_3390_jcdd11060161 crossref_primary_10_1002_cpdd_1091 crossref_primary_10_1111_1756_185X_14382 crossref_primary_10_1007_s00394_024_03397_9 crossref_primary_10_7759_cureus_57764 crossref_primary_10_2174_1389450121999201125200558 crossref_primary_10_1093_rheumatology_keac659 crossref_primary_10_2174_0115733971251184230921042511 crossref_primary_10_3389_fmed_2020_00446 crossref_primary_10_3390_brainsci15030232 crossref_primary_10_3389_fgene_2021_673180 crossref_primary_10_1039_D2NA00229A crossref_primary_10_1155_2024_8816919 crossref_primary_10_1038_s41598_025_86073_0 crossref_primary_10_1016_j_cyto_2022_156007 crossref_primary_10_15421_022175 crossref_primary_10_3390_antiox13070775 crossref_primary_10_1111_sji_13245 crossref_primary_10_12677_ACM_2023_133609 crossref_primary_10_1002_jcph_2292 crossref_primary_10_3390_cells11010043 crossref_primary_10_3389_fimmu_2024_1408501 crossref_primary_10_1007_s00210_023_02810_0 crossref_primary_10_3390_cancers14133039 crossref_primary_10_1016_j_colsurfa_2024_133521 crossref_primary_10_4103_pajo_pajo_87_24 crossref_primary_10_1002_iid3_1121 crossref_primary_10_2174_0115672018270434240105110330 crossref_primary_10_3390_cells10112857 crossref_primary_10_3390_ph16030385 crossref_primary_10_1016_j_rcreu_2021_01_007 crossref_primary_10_1007_s10787_020_00736_0 crossref_primary_10_1186_s12906_023_03864_6 crossref_primary_10_1016_j_ijpharm_2024_124829 crossref_primary_10_4078_jrd_22_0053 crossref_primary_10_1007_s13346_022_01260_0 crossref_primary_10_1177_1934578X241247518 crossref_primary_10_33137_juls_v16i1_39048 crossref_primary_10_1007_s40744_022_00475_4 crossref_primary_10_4103_SBVJ_SBVJ_9_24 crossref_primary_10_1007_s12018_021_09280_z crossref_primary_10_1016_j_heliyon_2023_e15054 crossref_primary_10_1136_ard_2024_226067 crossref_primary_10_1093_pm_pnab054 crossref_primary_10_1148_rg_210146 crossref_primary_10_5812_gct_111097 crossref_primary_10_1016_j_jtauto_2023_100198 crossref_primary_10_1139_cjpp_2023_0259 crossref_primary_10_1002_tox_23818 crossref_primary_10_1007_s13346_024_01786_5 crossref_primary_10_1063_5_0233961 crossref_primary_10_2174_1872210518666230905155459 crossref_primary_10_3389_fphar_2019_01085 crossref_primary_10_1007_s10787_025_01664_7 crossref_primary_10_1016_j_ejr_2022_08_002 crossref_primary_10_3389_fendo_2022_922070 crossref_primary_10_2174_1389450121666201027124625 crossref_primary_10_1007_s12018_020_09271_6 crossref_primary_10_12998_wjcc_v9_i28_8413 crossref_primary_10_1016_j_lfs_2022_121257 crossref_primary_10_1016_j_lfs_2023_121411 crossref_primary_10_1089_mab_2023_0019 crossref_primary_10_1016_j_ijbiomac_2024_130645 crossref_primary_10_3390_ijms25063242 crossref_primary_10_3390_molecules27217223 crossref_primary_10_51847_OEZ9qd2qTC crossref_primary_10_1615_CritRevTherDrugCarrierSyst_v42_i3_10 crossref_primary_10_3389_fimmu_2022_1007610 crossref_primary_10_1016_j_arabjc_2020_10_030 crossref_primary_10_1007_s10067_024_07234_6 crossref_primary_10_1016_j_msec_2021_112585 crossref_primary_10_1080_02726351_2025_2475110 crossref_primary_10_1039_D1TB00802A crossref_primary_10_3390_pharmaceutics14081736 crossref_primary_10_1016_j_jddst_2022_103175 crossref_primary_10_7759_cureus_54589 crossref_primary_10_3390_jpm13121633 crossref_primary_10_3390_polym13101539 crossref_primary_10_4103_ijnmr_ijnmr_84_21 crossref_primary_10_3390_diagnostics12071560 crossref_primary_10_1016_j_jep_2021_114921 crossref_primary_10_3390_life13102058 crossref_primary_10_3389_fphar_2024_1456216 crossref_primary_10_3390_ijms231810297 crossref_primary_10_1016_j_procbio_2022_07_022 crossref_primary_10_1515_biol_2022_0611 |
| Cites_doi | 10.1002/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X 10.3346/jkms.2017.32.7.1207 10.1186/1741-7015-11-88 10.1080/17453674.2000.11744845 10.2174/1381612820666140825123104 10.1016/j.semarthrit.2006.08.006 10.1056/NEJMra1004965 10.1093/rheumatology/keu328 10.1186/s13075-016-1052-8 10.1097/BOR.0000000000000487 10.1039/C4TB01005A 10.2147/DDDT.S41645 10.1038/nrdp.2018.1 10.1136/ard.2009.126532 10.1155/2017/2690402 10.4103/1450-1147.150509 10.1136/annrheumdis-2016-210602 10.1007/s11420-005-0133-z 10.3748/wjg.v21.i40.11282 10.5114/aoms.2014.47827 10.1007/s12178-013-9178-7 10.1038/ncomms14913 10.1136/ard.2009.112474 10.4061/2011/681640 10.1186/1710-1492-9-30 10.1007/s40744-017-0073-3 10.4161/mabs.2.6.13493 10.1016/j.clinthera.2011.05.044 10.1136/rmdopen-2016-000404 10.4137/CMAMD.S5558 10.1038/nrd.2016.21 10.1177/2042098611406318 10.1007/s00264-009-0820-3 10.1016/j.berh.2008.07.001 10.6061/clinics/2013(06)07 10.1161/CIRCRESAHA.116.302317 10.1016/j.jhsa.2011.01.019 10.2165/00063030-199912040-00007 10.1093/rheumatology/kes032 10.3899/jrheum.120338 10.1038/tpj.2013.48 10.1310/hpj4805-413 10.3121/cmr.2007.698 10.1136/annrheumdis-2015-207524 |
| ContentType | Journal Article |
| Copyright | 2018 The Author(s) Published by S. Karger AG, Basel 2018 The Author(s) Published by S. Karger AG, Basel. Copyright © 2018 by S. Karger AG, Basel 2018 |
| Copyright_xml | – notice: 2018 The Author(s) Published by S. Karger AG, Basel – notice: 2018 The Author(s) Published by S. Karger AG, Basel. – notice: Copyright © 2018 by S. Karger AG, Basel 2018 |
| DBID | M-- AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1159/000493390 |
| DatabaseName | Karger Open Access Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central (New) ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed CrossRef ProQuest One Academic Middle East (New) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: M-- name: Karger Open Access Journals url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1423-0151 |
| EndPage | 507 |
| ExternalDocumentID | PMC6422329 30173215 10_1159_000493390 493390 |
| Genre | Journal Article Review |
| GroupedDBID | --- 0R~ 0~B 30W 326 36B 3O. 3V. 4.4 53G 5GY 7X7 88E 8FI 8FJ 8UI AAWTL AAYIC ABPAZ ABUWG ACGFS ADBBV AENEX AEYAO AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CS3 CYUIP DIK DU5 E0A E3Z EBS EJD EMB EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HYE HZ~ IAO IHR KUZGX M-- M1P MK0 O1H O9- OK1 P2P PQQKQ PROAC PSQYO RKO RNS RPM SV3 UJ6 UKHRP AAYXX ABBTS ABWCG ACQXL ADAGL AFJJK AFSIO AHFRZ AIOBO CAG CITATION COF ITC PHGZM PHGZT RIG RXVBD TR2 NPM PJZUB PPXIY 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c585t-a4819f40fe597e299eea350bf193771ec917fb21da4057473490ee953db480d53 |
| IEDL.DBID | M-- |
| ISSN | 1011-7571 1423-0151 |
| IngestDate | Thu Aug 21 18:19:50 EDT 2025 Fri Jul 11 00:25:46 EDT 2025 Fri Jul 25 02:24:26 EDT 2025 Mon Jul 21 05:53:36 EDT 2025 Thu Apr 24 23:08:14 EDT 2025 Tue Jul 01 05:11:02 EDT 2025 Thu Aug 29 12:04:35 EDT 2024 Thu Sep 05 20:30:31 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Boutonnière deformity Rheumatoid arthritis Swan neck deformity |
| Language | English |
| License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. https://creativecommons.org/licenses/by-nc/4.0 2018 The Author(s) Published by S. Karger AG, Basel. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c585t-a4819f40fe597e299eea350bf193771ec917fb21da4057473490ee953db480d53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://karger.com/doi/10.1159/000493390 |
| PMID | 30173215 |
| PQID | 2301913388 |
| PQPubID | 2047984 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6422329 crossref_primary_10_1159_000493390 proquest_miscellaneous_2099038632 pubmed_primary_30173215 karger_primary_493390 crossref_citationtrail_10_1159_000493390 proquest_journals_2301913388 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-01-01 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Basel, Switzerland |
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel – name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch |
| PublicationTitle | Medical principles and practice |
| PublicationTitleAlternate | Med Princ Pract |
| PublicationYear | 2018 |
| Publisher | S. Karger AG |
| Publisher_xml | – name: S. Karger AG |
| References | Staheli LT. Lower extremity management. In: Staheli LT, Hall JG, Jaffe KM, Paholke DO, editors. Arthrogryposis: A Text Atlas. Cambridge: Cambridge University Press; 1998. pp. 55–73. Cada DJ, Demaris K, Levien TL, Baker DE. Tofacitinib. Hosp Pharm. 2013May;48(5):413–24. 10.1310/hpj4805-413244214980018-5787 Zitnay JL, Li Y, Qin Z, San BH, Depalle B, Reese SP, et al.. Molecular level detection and localization of mechanical damage in collagen enabled by collagen hybridizing peptides. Nat Commun. 2017Mar;8:14913. 10.1038/ncomms14913283276102041-1723 Sailaja AK. An overall review on rheumatoid arthritis. Journal of Current Pharma Research. 2014;4:1138–43. Pajarinen J, Lin TH, Sato T, Yao Z, Goodman SB. Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med. 2014Nov;2(41):7094–108. 10.1039/C4TB01005A255415912050-750X Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010Jun;69(6):964–75. 10.1136/ard.2009.126532204447500003-4967 Puddu G, Cipolla M, Cerullo G, Franco V, Giannì E. Which osteotomy for a valgus knee. Int Orthop. 2010Feb;34(2):239–47. 10.1007/s00264-009-0820-3195479720341-2695 den Broeder AA, van Herwaarden N, van den Bemt BJ. Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts. Curr Opin Rheumatol. 2018May;30(3):266–75. 10.1097/BOR.0000000000000487293898291040-8711 Brooks F, Hariharan K. The rheumatoid forefoot. Curr Rev Musculoskelet Med. 2013Dec;6(4):320–7. 10.1007/s12178-013-9178-7239432971935-973X Gibofsky A. Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J. 2006Feb;2(1):30–41. 10.1007/s11420-005-0133-z187518441556-3316 Knut L. Radiosynovectomy in the therapeutic management of arthritis. World J Nucl Med. 2015Jan-Apr;14(1):10–5. 10.4103/1450-1147.150509257095381450-1147 Rein P, Mueller RB. Treatment with Biologicals in Rheumatoid Arthritis: an Overview. Rheumatol Ther. 2017Dec;4(2):247–61. 10.1007/s40744-017-0073-3288317122198-6576 Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006Dec;36(3):182–8. 10.1016/j.semarthrit.2006.08.006170456300049-0172 Silva JC, Mariz HA, Rocha LFJr, OliveiraPS, Dantas AT, Duarte AL, et al.. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (São Paulo). 2013Jun;68(6):766–71. 10.6061/clinics/2013(06)07237784831807-5932 Gay RD, Clarke AW, Elgundi Z, Domagala T, Simpson RJ, Le NB, et al.. Anti-TNFα domain antibody construct CEP-37247: full antibody functionality at half the size. MAbs. 2010Nov-Dec;2(6):625–38. 10.4161/mabs.2.6.13493209305151942-0862 Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al.. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016Jan;75(1):3–15. 10.1136/annrheumdis-2015-207524259694300003-4967 Gómez-Gómez GJ, Masedo Á, Yela C, Martínez-Montiel MP, Casís B. Current stage in inflammatory bowel disease: what is next. World J Gastroenterol. 2015Oct;21(40):11282–303. 10.3748/wjg.v21.i40.11282265250131007-9327 Mann DL. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015Mar;116(7):1254–68. 10.1161/CIRCRESAHA.116.302317258146860009-7330 McGonagle D, Hermann KG, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015Jan;54(1):29–38. 10.1093/rheumatology/keu328252311771462-0324 Piyarulli D, Koolaee RM. A 22-Year-Old Female With Joint Pain. In: Piyarulli D, Koolaee RM, editors. Medicine Morning Report: Beyond the Pearls. Philadelphia: Elsevier; 2016. pp. 65–77. Rosman Z, Shoenfeld Y, Zandman-Goddard G. Biologic therapy for autoimmune diseases: an update. BMC Med. 2013Apr;11(1):88. 10.1186/1741-7015-11-88235575131741-7015 Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008Aug;22(4):583–604. 10.1016/j.berh.2008.07.001187837391521-6942 Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, et al.. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum. 1999Sep;42(9):1927–35. 10.1002/1529-0131(199909)42:9[{LT}]1927::AID-ANR19[{GT}]3.0.CO;2-X105138090004-3591 González-Álvaro I, Ortiz AM, Seoane IV, García-Vicuña R, Martínez C, Gomariz RP. Biomarkers predicting a need for intensive treatment in patients with early arthritis. Curr Pharm Des. 2015;21(2):170–81. 10.2174/1381612820666140825123104251637411381-6128 Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, et al.. Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J. 2014Apr;14(2):93–106. 10.1038/tpj.2013.48245899101470-269X Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007Mar;5(1):19–34. 10.3121/cmr.2007.698174568321539-4182 Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Kirschbaum BJ. How does leflunomide modulate the immune response in rheumatoid arthritis. BioDrugs. 1999Oct;12(4):301–15. 10.2165/00063030-199912040-00007180311841173-8804 Escott-Stump S. Nutrition and Diagnosis-Related Care. Philadelphia: Lippincott Williams & Wilkins; 2011. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011Dec;365(23):2205–19. 10.1056/NEJMra1004965221500390028-4793 Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al.. Rheumatoid arthritis. Nat Rev Dis Primers. 2018Feb;4:18001. 10.1038/nrdp.2018.1294179362056-676X Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, et al.. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017Jun;76(6):948–59. 10.1136/annrheumdis-2016-210602279798730003-4967 Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al.. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013Aug;9(1):30. 10.1186/1710-1492-9-30239475901710-1484 Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, et al.. The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016Mar-Apr;34(2):318–28.269667910392-856X Halstead JA, Stoten S. Orthopedic Nursing: Caring for Patients with Musculoskeletal Disorders. Bridgewater: Western Schools; 2010. ShielWCJr. Rheumatoid Arthritis. 2017. http://www.medicinenet.com/rheumatoid_arthritis/article.htm (accesses May 12, 2017) Nakamura S, Suzuki K, Iijima H, Hata Y, Lim CR, Ishizawa Y, et al.. Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study. Arthritis Res Ther. 2016Jul;18(1):159. 10.1186/s13075-016-1052-8274352421478-6354 Lee JE, Kim IJ, Cho MS, Lee J. A Case of Rheumatoid Vasculitis Involving Hepatic Artery in Early Rheumatoid Arthritis. J Korean Med Sci. 2017Jul;32(7):1207–10. 10.3346/jkms.2017.32.7.1207285812811011-8934 Mok CC. Rituximab for the treatment of rheumatoid arthritis: an update. Drug Des Devel Ther. 2013Dec;8:87–100. 10.2147/DDDT.S41645244038231177-8881 Fox CQ, Ahmed SS. Physician Assistant’s Clinical Review Cards. Philadelphia: F. A. Davis Company; 2002. pp. 138–9. Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65(3):168–73.179226641936-9719 Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2013Aug;6:35–43. 10.4137/CMAMD.S5558239975761179-5441 Emer JJ, Claire W. Rituximab: a review of dermatological applications. J Clin Aesthet Dermatol. 2009May;2(5):29–37.207299621941-2789 Rheumatic surgery-overview/Surgical treatment-general opinions. Acta Orthop Scand. 2000;71(sup294Suppl 294):8–14. 10.1080/17453674.2000.117448450001-6470 Chung KC, Pushman AG. Current concepts in the management of the rheumatoid hand. J Hand Surg Am. 2011Apr;36(4):736–47. 10.1016/j.jhsa.2011.01.019214637360363-5023 Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012Sep;90(0):21–7. 10.3899/jrheum.120338229423250380-0903 Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al.. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford). 2012Aug;51(8):1416–25. 10.1093/rheumatology/kes032224478861462-0324 Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov. 2016May;15(5):305–6. 10.1038/nrd.2016.21270800401474-1776 Centers for Disease Control and Prevention. (2016). Physical Activity for Arthritis.https://www.cdc.gov/arthritis/basics/physical-activity-overview.html (accessed April 25, 2017) Lis K, Kuzawińska O, Bałkowiec-Iskra E. Tumor necrosis factor inhibitors - state of knowledge. Arch Med Sci. 2014Dec;10(6):1175–85. 10.5114/aoms.2014.47827256248561734-1922 Perpétuo IP, Caetano-Lopes J, Rodrigues AM, Campanilho-Marques R, Ponte C, Canhão H, et al.. Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursor ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref44 ref21 ref43 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
| References_xml | – reference: Centers for Disease Control and Prevention. (2016). Physical Activity for Arthritis.https://www.cdc.gov/arthritis/basics/physical-activity-overview.html (accessed April 25, 2017) – reference: Brooks F, Hariharan K. The rheumatoid forefoot. Curr Rev Musculoskelet Med. 2013Dec;6(4):320–7. 10.1007/s12178-013-9178-7239432971935-973X – reference: Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2013Aug;6:35–43. 10.4137/CMAMD.S5558239975761179-5441 – reference: Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al.. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013Aug;9(1):30. 10.1186/1710-1492-9-30239475901710-1484 – reference: ShielWCJr. Rheumatoid Arthritis. 2017. http://www.medicinenet.com/rheumatoid_arthritis/article.htm (accesses May 12, 2017) – reference: Zitnay JL, Li Y, Qin Z, San BH, Depalle B, Reese SP, et al.. Molecular level detection and localization of mechanical damage in collagen enabled by collagen hybridizing peptides. Nat Commun. 2017Mar;8:14913. 10.1038/ncomms14913283276102041-1723 – reference: Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A. One year in review: the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2015Jul-Aug;33(4):551–8.262039330392-856X – reference: Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, et al.. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011Feb;2011:681640. 10.4061/2011/681640214038332090-2204 – reference: Rein P, Mueller RB. Treatment with Biologicals in Rheumatoid Arthritis: an Overview. Rheumatol Ther. 2017Dec;4(2):247–61. 10.1007/s40744-017-0073-3288317122198-6576 – reference: Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006Dec;36(3):182–8. 10.1016/j.semarthrit.2006.08.006170456300049-0172 – reference: Pajarinen J, Lin TH, Sato T, Yao Z, Goodman SB. Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med. 2014Nov;2(41):7094–108. 10.1039/C4TB01005A255415912050-750X – reference: Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov. 2016May;15(5):305–6. 10.1038/nrd.2016.21270800401474-1776 – reference: Tovey MG, Lallemand C. Immunogenicity and other problems associated with the use of biopharmaceuticals. Ther Adv Drug Saf. 2011Jun;2(3):113–28. 10.1177/2042098611406318250832072042-0986 – reference: Curtis JR, Singh JA. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011Jun;33(6):679–707. 10.1016/j.clinthera.2011.05.044217042340149-2918 – reference: Gómez-Gómez GJ, Masedo Á, Yela C, Martínez-Montiel MP, Casís B. Current stage in inflammatory bowel disease: what is next. World J Gastroenterol. 2015Oct;21(40):11282–303. 10.3748/wjg.v21.i40.11282265250131007-9327 – reference: Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008Aug;22(4):583–604. 10.1016/j.berh.2008.07.001187837391521-6942 – reference: Silva JC, Mariz HA, Rocha LFJr, OliveiraPS, Dantas AT, Duarte AL, et al.. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (São Paulo). 2013Jun;68(6):766–71. 10.6061/clinics/2013(06)07237784831807-5932 – reference: Mann DL. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015Mar;116(7):1254–68. 10.1161/CIRCRESAHA.116.302317258146860009-7330 – reference: Mok CC. Rituximab for the treatment of rheumatoid arthritis: an update. Drug Des Devel Ther. 2013Dec;8:87–100. 10.2147/DDDT.S41645244038231177-8881 – reference: McGonagle D, Hermann KG, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015Jan;54(1):29–38. 10.1093/rheumatology/keu328252311771462-0324 – reference: Piyarulli D, Koolaee RM. A 22-Year-Old Female With Joint Pain. In: Piyarulli D, Koolaee RM, editors. Medicine Morning Report: Beyond the Pearls. Philadelphia: Elsevier; 2016. pp. 65–77. – reference: Sailaja AK. An overall review on rheumatoid arthritis. Journal of Current Pharma Research. 2014;4:1138–43. – reference: Emer JJ, Claire W. Rituximab: a review of dermatological applications. J Clin Aesthet Dermatol. 2009May;2(5):29–37.207299621941-2789 – reference: Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, et al.. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum. 1999Sep;42(9):1927–35. 10.1002/1529-0131(199909)42:9[{LT}]1927::AID-ANR19[{GT}]3.0.CO;2-X105138090004-3591 – reference: Gay RD, Clarke AW, Elgundi Z, Domagala T, Simpson RJ, Le NB, et al.. Anti-TNFα domain antibody construct CEP-37247: full antibody functionality at half the size. MAbs. 2010Nov-Dec;2(6):625–38. 10.4161/mabs.2.6.13493209305151942-0862 – reference: Perpétuo IP, Caetano-Lopes J, Rodrigues AM, Campanilho-Marques R, Ponte C, Canhão H, et al.. Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis. BioMed Res Int. 2017;2017:2690402. 10.1155/2017/2690402282867572314-6133 – reference: Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, et al.. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017Jun;76(6):948–59. 10.1136/annrheumdis-2016-210602279798730003-4967 – reference: Staheli LT. Lower extremity management. In: Staheli LT, Hall JG, Jaffe KM, Paholke DO, editors. Arthrogryposis: A Text Atlas. Cambridge: Cambridge University Press; 1998. pp. 55–73. – reference: Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012Sep;90(0):21–7. 10.3899/jrheum.120338229423250380-0903 – reference: Knut L. Radiosynovectomy in the therapeutic management of arthritis. World J Nucl Med. 2015Jan-Apr;14(1):10–5. 10.4103/1450-1147.150509257095381450-1147 – reference: Daien CI, Hua C, Combe B, Landewe R. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open. 2017Jan;3(1):e000404. 10.1136/rmdopen-2016-000404281515392399-4983 – reference: Gibofsky A. Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J. 2006Feb;2(1):30–41. 10.1007/s11420-005-0133-z187518441556-3316 – reference: Nakamura S, Suzuki K, Iijima H, Hata Y, Lim CR, Ishizawa Y, et al.. Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study. Arthritis Res Ther. 2016Jul;18(1):159. 10.1186/s13075-016-1052-8274352421478-6354 – reference: Louie GH, Ward MM. Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis. 2010May;69(5):868–71. 10.1136/ard.2009.112474195812790003-4967 – reference: Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, et al.. The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016Mar-Apr;34(2):318–28.269667910392-856X – reference: Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Kirschbaum BJ. How does leflunomide modulate the immune response in rheumatoid arthritis. BioDrugs. 1999Oct;12(4):301–15. 10.2165/00063030-199912040-00007180311841173-8804 – reference: Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al.. Rheumatoid arthritis. Nat Rev Dis Primers. 2018Feb;4:18001. 10.1038/nrdp.2018.1294179362056-676X – reference: Rheumatic surgery-overview/Surgical treatment-general opinions. Acta Orthop Scand. 2000;71(sup294Suppl 294):8–14. 10.1080/17453674.2000.117448450001-6470 – reference: Rosman Z, Shoenfeld Y, Zandman-Goddard G. Biologic therapy for autoimmune diseases: an update. BMC Med. 2013Apr;11(1):88. 10.1186/1741-7015-11-88235575131741-7015 – reference: Halstead JA, Stoten S. Orthopedic Nursing: Caring for Patients with Musculoskeletal Disorders. Bridgewater: Western Schools; 2010. – reference: Chung KC, Pushman AG. Current concepts in the management of the rheumatoid hand. J Hand Surg Am. 2011Apr;36(4):736–47. 10.1016/j.jhsa.2011.01.019214637360363-5023 – reference: Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, et al.. Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J. 2014Apr;14(2):93–106. 10.1038/tpj.2013.48245899101470-269X – reference: Lee JE, Kim IJ, Cho MS, Lee J. A Case of Rheumatoid Vasculitis Involving Hepatic Artery in Early Rheumatoid Arthritis. J Korean Med Sci. 2017Jul;32(7):1207–10. 10.3346/jkms.2017.32.7.1207285812811011-8934 – reference: Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010Jun;69(6):964–75. 10.1136/ard.2009.126532204447500003-4967 – reference: Puddu G, Cipolla M, Cerullo G, Franco V, Giannì E. Which osteotomy for a valgus knee. Int Orthop. 2010Feb;34(2):239–47. 10.1007/s00264-009-0820-3195479720341-2695 – reference: Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al.. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016Jan;75(1):3–15. 10.1136/annrheumdis-2015-207524259694300003-4967 – reference: Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65(3):168–73.179226641936-9719 – reference: Cada DJ, Demaris K, Levien TL, Baker DE. Tofacitinib. Hosp Pharm. 2013May;48(5):413–24. 10.1310/hpj4805-413244214980018-5787 – reference: Lis K, Kuzawińska O, Bałkowiec-Iskra E. Tumor necrosis factor inhibitors - state of knowledge. Arch Med Sci. 2014Dec;10(6):1175–85. 10.5114/aoms.2014.47827256248561734-1922 – reference: Escott-Stump S. Nutrition and Diagnosis-Related Care. Philadelphia: Lippincott Williams & Wilkins; 2011. – reference: González-Álvaro I, Ortiz AM, Seoane IV, García-Vicuña R, Martínez C, Gomariz RP. Biomarkers predicting a need for intensive treatment in patients with early arthritis. Curr Pharm Des. 2015;21(2):170–81. 10.2174/1381612820666140825123104251637411381-6128 – reference: Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007Mar;5(1):19–34. 10.3121/cmr.2007.698174568321539-4182 – reference: Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al.. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford). 2012Aug;51(8):1416–25. 10.1093/rheumatology/kes032224478861462-0324 – reference: McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011Dec;365(23):2205–19. 10.1056/NEJMra1004965221500390028-4793 – reference: den Broeder AA, van Herwaarden N, van den Bemt BJ. Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts. Curr Opin Rheumatol. 2018May;30(3):266–75. 10.1097/BOR.0000000000000487293898291040-8711 – reference: Fox CQ, Ahmed SS. Physician Assistant’s Clinical Review Cards. Philadelphia: F. A. Davis Company; 2002. pp. 138–9. – ident: ref16 doi: 10.1002/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X – ident: ref1 doi: 10.3346/jkms.2017.32.7.1207 – ident: ref29 doi: 10.1186/1741-7015-11-88 – ident: ref37 doi: 10.1080/17453674.2000.11744845 – ident: ref43 doi: 10.2174/1381612820666140825123104 – ident: ref4 doi: 10.1016/j.semarthrit.2006.08.006 – ident: ref2 doi: 10.1056/NEJMra1004965 – ident: ref6 doi: 10.1093/rheumatology/keu328 – ident: ref42 doi: 10.1186/s13075-016-1052-8 – ident: ref21 doi: 10.1097/BOR.0000000000000487 – ident: ref38 doi: 10.1039/C4TB01005A – ident: ref28 doi: 10.2147/DDDT.S41645 – ident: ref7 doi: 10.1038/nrdp.2018.1 – ident: ref13 doi: 10.1136/ard.2009.126532 – ident: ref25 doi: 10.1155/2017/2690402 – ident: ref34 doi: 10.4103/1450-1147.150509 – ident: ref9 doi: 10.1136/annrheumdis-2016-210602 – ident: ref19 doi: 10.1007/s11420-005-0133-z – ident: ref30 doi: 10.3748/wjg.v21.i40.11282 – ident: ref24 doi: 10.5114/aoms.2014.47827 – ident: ref36 doi: 10.1007/s12178-013-9178-7 – ident: ref40 doi: 10.1038/ncomms14913 – ident: ref32 doi: 10.1136/ard.2009.112474 – ident: ref39 doi: 10.4061/2011/681640 – ident: ref10 doi: 10.1186/1710-1492-9-30 – ident: ref20 doi: 10.1007/s40744-017-0073-3 – ident: ref23 doi: 10.4161/mabs.2.6.13493 – ident: ref27 doi: 10.1016/j.clinthera.2011.05.044 – ident: ref14 doi: 10.1136/rmdopen-2016-000404 – ident: ref17 doi: 10.4137/CMAMD.S5558 – ident: ref3 doi: 10.1038/nrd.2016.21 – ident: ref22 doi: 10.1177/2042098611406318 – ident: ref35 doi: 10.1007/s00264-009-0820-3 – ident: ref5 doi: 10.1016/j.berh.2008.07.001 – ident: ref15 doi: 10.6061/clinics/2013(06)07 – ident: ref26 doi: 10.1161/CIRCRESAHA.116.302317 – ident: ref33 doi: 10.1016/j.jhsa.2011.01.019 – ident: ref18 doi: 10.2165/00063030-199912040-00007 – ident: ref11 doi: 10.1093/rheumatology/kes032 – ident: ref12 doi: 10.3899/jrheum.120338 – ident: ref41 doi: 10.1038/tpj.2013.48 – ident: ref31 doi: 10.1310/hpj4805-413 – ident: ref8 doi: 10.3121/cmr.2007.698 – ident: ref44 doi: 10.1136/annrheumdis-2015-207524 |
| SSID | ssj0008330 |
| Score | 2.61212 |
| SecondaryResourceType | review_article |
| Snippet | Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors... |
| SourceID | pubmedcentral proquest pubmed crossref karger |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 501 |
| SubjectTerms | Analgesics Aspirin Autoimmune diseases Drug dosages Exercise Gene expression Inflammation Joint surgery Mini Review Narcotics Nonsteroidal anti-inflammatory drugs Nurse specialists Pain Patients Physical fitness Rheumatoid arthritis |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-QwEB88PcQX0fOrftETH-4l2G6STeuLqCgi7J2Iwr6VpklYUdpVd_Xfd6ZN6wdyr5kpLZlk5jcfnQHYLziaaR1LpoRQTKR5xDSCOIbgtd-XPWN6Ef3vPPjbv7gVl0M59AG3Z19W2erEWlGbqqAY-QFCZXQt0KFKjsaPjKZGUXbVj9D4AXPUuoxKutSwc7gQXfCmG0EcMyVV7DsLoQU_qKEx56SKP9ijn_dUfv30Hdr8WjT5wQqdL8Gih4_hcSPvZZix5S-YH_gE-Qqo65GdIgit7gwxjeqWRYfhcXiCLrEL_72QarCvYeVCRH7hTVtmvgq352c3pxfMz0ZgBQL8CcsFmnInImfRI7BoU6zNuYy0Q0CmVGwLdMOc7sUmJ0QmFBdpZG0qudEiiYzkazBbVqXdgDASOikIJ2mVCKqNSp2Ji8RIipBqJwL40-5QVvjG4TS_4iGrHQiZZt1mBrDXsY6bbhnfMa0229yxtOvbX9YHV1cNKRsbh-RWKJm_Z8_Z-6kI4HdHxhtCaY-8tNUUeSj3x5M-7wWw3siwewM-rjiingDUJ-l2DNR9-zOlvBvVXbjRccNjnm7-_7O2YAEhVtIEbbZhdvI0tTsIYyZ6tz6rb3ea7S4 priority: 102 providerName: ProQuest |
| Title | Rheumatoid Arthritis: A Brief Overview of the Treatment |
| URI | https://karger.com/doi/10.1159/000493390 https://www.ncbi.nlm.nih.gov/pubmed/30173215 https://www.proquest.com/docview/2301913388 https://www.proquest.com/docview/2099038632 https://pubmed.ncbi.nlm.nih.gov/PMC6422329 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1bS8MwFD54Q3wR79bLqOKDL8G2SZbWNxVFhM0xNthbaZqEDaUV3fTve9IbbszX5JTQnCTn-5KTLwBXKcUwLX1OBGOCsCjxiEQQRxC8tts8UCrw7H3nTrf9PGQvIz6q9jvsXZg3m_9cSKM22gIYcG8KJEuRn6_COvIoalXyO4Q0a25Iaak74PtEcOFXGkJzn27BJo5mQQP7BO6fILRRtrkMYi5mSv4JPU87sF1hRveudPIurOhsDzY71an4Poj-WM8QeeYTZY3GhU7RrXvnIvPXxn39tuuB_nFz4yLccwd1bvkBDJ8eBw_PpHoQgaSI6qckYRi_DfOMRhqgMZBonVDuSYMoTAhfp8i9jAx8lVgYxgRlkad1xKmSLPQUp4ewluWZPgbXYzJMLTiSImQ2ISoyyk9Dxe22qDTMgeu6h-K0Ugu3j1a8xwVr4FHc9KsDl43pRymRsczooOzmxqQuP1so7_R6ZVX8oQxW106Jq8n1FSNrQpaJ3Dp04KKpxmlhzzqSTOcztLEHfjRs08CBo9KHTQv1KHBAzHm3MbCS2_M12WRcSG8jW8OxHZ388zensIWAKiy3aM5gbfo50-cIWqayBatiJFqwfv_Y7fVbBfVvFWP4F21g5Sg |
| linkProvider | Karger AG |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3dT9RAEMAn5DDqi_EDtYq6Gk182dB2t7ctCTGgkEO480KOhLfS7e7miKY94U7CP-XfyEy_BEJ847U7TZud3dnf7M7OAHzMBS7TOoi4klJxmWQ-1whxHOG1349CY0Kf7jsPR_3Bofx-FB0twd_2LgyFVbY2sTLUpsxpj3wNURldC3So4i-z35yqRtHpaltCox4We_biHF22s43db6jfT2G4sz35OuBNVQGeIxrPeSZxEXTSdxZZ2qI1tjYTka8dooxSgc3RgXE6DExGLCOVkIlvbRIJo2XsG6oSgSZ_WQp0ZXqwvLU9Gh90tj8Wos5_EARcRSpochkhM6xVMC4EGf8rK-C9nxTwfXob394M07yy7u08hkcNsLLNeoQ9gSVbPIX7w-ZI_hmog6ldIPaWJ4aEplWSpHW2ybbQCXfsxx8yRvaclY4ha7JJG9i-Aod30m_PoVeUhX0JzJc6zonMtIolRWMlzgR5bCLak9VOevC57aE0b1KVU8WMX2nlskRJ2nWmBx860Vmdn-M2oZW6mzuR9vnqjefD8bhuSmfGYXOrlLSZ2Wfpv3HowfuuGeckHbRkhS0XKEOnjSLui9CDF7UOuy_g60ogZ3mgrmm3E6B839dbipNplfcbXUWcWMmr___WO3gwmAz30_3d0d5reIiAF9dbRqvQm58u7BuEqLl-24xcBsd3PVkuAWvAKlo |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3db9MwEMBP00ATL4iPARkDDAKJF6tJbNcJEkKDUW2MjgptUt-yOLbVCZR0W8vEv8Zfx12-2KaJt73GF7WyfXe_sy93AK8LgW7aRIprKTWXaR5ygxDHEV6HQxVbG4f0vfN4f7hzKL9M1XQF_nTfwlBaZWcTa0Ntq4LOyAeIyhhaYECVDHybFjHZHn2Yn3DqIEU3rV07jWaL7Lnf5xi-nb3f3ca1fhPHo88Hn3Z422GAF4jJC55LdIheht4hVzu0zM7lQoXGI9ZoHbkCgxlv4sjmxDVSC5mGzqVKWCOT0FLHCDT_t7RQEemYnvbBHpKNaCohRBHXSkdtVSOkh0GN5UKQG7jgC2__oNTv0-tI92rC5gUPOLoHd1t0ZVvNXrsPK658AGvj9nL-IejvM7dEAK6OLQnN6nJJ79gW-4jhuGfffpFZcues8gypkx10Ke7rcHgjs_YIVsuqdE-AhdIkBTGa0YmkvKzU26hIrKLTWeNlAG-7GcqKtmg59c74mdXBi0qzfjIDeNWLzptKHdcJrTfT3It0zzevPB9PJs1QNrceh7tFyVodP8v-7cgAXvbDqJ105ZKXrlqiDN07imQo4gAeN2vY_wK-rgUSVwD60ur2AlT5-_JIeTyrK4Bj0Igqlm78_2-9gDVUkezr7v7eU7iDpJc0Z0ebsLo4XbpnSFML87zetgyOblpP_gI8ny0q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rheumatoid+Arthritis%3A+A+Brief+Overview+of+the+Treatment&rft.jtitle=Medical+principles+and+practice&rft.au=Bullock%2C+Jacqueline&rft.au=Rizvi%2C+Syed+A.A.&rft.au=Saleh%2C+Ayman+M.&rft.au=Ahmed%2C+Sultan+S.&rft.date=2018-01-01&rft.pub=S.+Karger+AG&rft.issn=1011-7571&rft.eissn=1423-0151&rft.volume=27&rft.issue=6&rft.spage=501&rft.epage=507&rft_id=info:doi/10.1159%2F000493390&rft_id=info%3Apmid%2F30173215&rft.externalDocID=PMC6422329 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon |